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Abstract.  TGF-B1  controls the expression of numer- 
ous genes, including early response and cellular ma- 
trix genes. However, the signal-transducing  mechanism 
underlying this regulation of gene expression is not 
fully understood.  In this study, we investigated 
whether redox regulation plays a  role in the TGF-/31 
signal transduction in the mouse osteoblastic cell line 
(MC3T3-E1).  The overall intracellular  oxidized state 
of the cells, when measured using 2',7'-dichlorofluores- 
cin diacetate by laser-scanning  confocal microscopy, 
was increased transiently  after the addition of TGF-/~ 1. 
This increase was abolished by the addition of oxygen 
radical  scavengers such as catalase and N-acetyl- 
cysteine. In a variant cell line lacking the TGF-B1 
receptor, the intracellular oxidized state was not 
modulated by treatment with TGF-fll. We then exam- 
ined the expression of early growth response-1  (egr-1) 
gene, which is inducible by TGF-fll and H202.  Radi- 
cal scavengers inhibited the induction of egr-1  by TGF- 
ill,  but not that by 12-O-tetradecanoylphorbol-13 ace- 
tate.  A  nuclear run-on assay indicated that this inhibi- 
tion was at the transcriptional  level. From transient 
expression experiments using chloramphenicol acetyl- 
transferase gene linked to serially deleted egr-1  gene 
5'-upstream region, the CArG element in the 5' flank- 
ing region of egr-1  was identified as an essential se- 
quence in the transcriptional  activation for both 
TGF-fll  and H202 stimulation.  These findings suggest 
that H202 acts as a mediator for the TGF-Bl-induced 
transcription  of egr-1  gene. 
T 
RANSFORMING  growth factor-/~l  is a multifunctional 
cytokine regulating  cell proliferation, differentiation, 
and other biological responses (Roberts and Sporn, 
1988; Barnard et al.,  1990).  The diverse biological effects 
exerted by TGF-/~I depend on cell types, growth status  of 
cells including culture conditions,  and the presence of other 
growth factors.  This factor was originally recognized as a 
stimulator for the anchorage-independent  growth of normal 
cells. However, it is now widely accepted as a potent growth 
inhibitor of epithelial cells in vitro (Massagu~,  1987; Masui 
et al.,  1986),  while it acts as a bifunctional regulator for 
mesenchymal-derived cells (Robey et al., 1987; Centrella et 
al.,  1987; Shibanuma et al.,  1991). 
TGF-B1 modulates the expression of a variety of genes: it 
increases  the  expression  of extracellular  matrix  proteins 
and protease inhibitor genes (Ignotz  and Massagu~,  1986; 
Roberts, et al.,  1988; Lund et al.,  1986; Thompson et al., 
1988) and it decreases the expression of genes for proteases 
that degrade matrix proteins (Edwards et al.,  1987; Kerr et 
al.,  1988).  TGF-B1 also induced the expression of imme- 
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diate-early response genes such as c-jun, junB, early growth 
response-1  (egr-1)  ~, and TSC-22  (Pertovaara  et al.,  1989; 
Koskinen et al., 1991; Shibanuma et al., 1992). Pietenpol et 
al. (1990a;  1990b) reported that the growth inhibition caused 
by TGF-B1 correlated with a decrease in c-myc gene tran- 
scription.  The products of the retinoblastoma gene and the 
p53 gene seem to be also involved in this growth inhibition 
and result in cell cycle arrest (Pietenpol et al., 1990b,  1991; 
Laiho et al.,  1990).  We have recently cloned a new TGF- 
/31-inducible gene (TSC-36) whose expresion reached a peak 
at 6-8 h after stimulation  with TGF-/5'I, and this gene seems 
to encode an extracellular  matrix protein (Shibanuma et al., 
1993). 
Although the multifaceted gene control actions of TGF-B1 
have been explored, the exact mechanisms by which TGF-/~I 
exerts  its effects is still  only partly understood.  Lin et al. 
(1992) recently cloned TGF-B1 type II receptor with a ser- 
ine/threonine  kinase  domain.  The  receptor acts as  a  key 
component in the transduction of TGF-~-signaling by form- 
1. Abbreviations used in this paper: CAT, chloramphenicol acetyltransfer- 
ase; DCFH-DA, 2',7'-dichlorofluorescin diacetate; DCFH, nonfluorescent 
polar derivative of DCFH-DA; egr-1, early growth response-1 (gene); GSH, 
intracellular glutathione; NAC, N-acetyl-L-cysteine;  PDI'C, pyrrolidine car- 
bodithioic acid ammonium; TPA, 12-O-tetradecanoylphorbol-13-acetate. 
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Figure 1. Changes in intracellular redox state of MC3T3-E1 cells 
after treatment with TGF-/~I. (a) Cells in precoulluent state were 
transferred to 0.1% BSA medium, and were treated with TGF-/31 
(5 ng/ml) for the indicated times (minutes). After treatment, me- 
dium was replaced with Hanks' solution containing 5 #M DCFH- 
DA, and fluorescence intensity was measured 5 min later with a 
confocal laser scanning microscope. (B) Relative fluorescence in- 
tensity of  each cell was calculated relative to untreated control cells. 
(o) Untreated MC3T3 cells, (e) MC3T3 cells treated with TGF-/31, 
(A) v-Ki-ras-transformed K1 cells treated with TGF-B1. (C) Cells 
were either treated with "I'GF-/~I (5 ng/ml) (column 2) for 75 rain 
or with H2Oz (columns 3-7) for 10 min. About 50 ceils were used 
for determination of each point.  The results show the means  + 
standard deviation. The experiment was repeated three times with 
reproducible results. 
ing a complex with type I receptor (Wrana et al.,  1992; Eb- 
ner et al., 1993). The involvement of G-protein (Howe et al., 
1990) and protein phosphatases as mediators of TGF-~I ac- 
tion has also been proposed (Gruppuso et al., 1991). In spite 
of these findings, the question of the signaling pathways from 
the receptor to nuclei and the nature of the  second mes- 
sengers still remains to be elucidated. 
Our previous findings suggest that the actions of "I'GF-B1 
could be mediated by hydrogen peroxide, H202. Both TGF- 
/51 and H~O~ reversibly blocked cells at the late G1 phase 
(Shibanuma et al.,  1991).  The cell cycle arrest by TGF-~I 
was  partly  abolished  by  catalase.  Furthermore,  TGF-/~I 
stimulated the release of H~O2 from the cells into the cul- 
ture medium in MC3T3-E1 cells. These observations suggest 
that H20~ is a mediator in the action of TGF-B1. 
Active oxygens are, in general, considered to be cytotoxic, 
damaging cells by inactivating and modifying the cellular 
components  (Cerutti,  1985).  However, accmulating  evi- 
dence suggests that oxygen radicals at low doses may func- 
tion as physiological mediators of cellular responses. For ex- 
ample, H202 was shown to mimic the activity of insulin in 
glucose transport and in  lipid  synthesis in rat adipocytes 
(Mukhwejee et al., 1978; May and De Haen, 1979). Schreck 
et al. (1991) and Schreck and Baeuerle (1991) reported that 
radical scavengers blocked the increase in NFKB-binding ac- 
tivity caused by tumor necrosis factor-a, and that H202 in- 
creased  NFKB-binding  activity.  H202  also  stimulated  the 
expression of immediate early response genes (Nose et al., 
i991). 
In the present study, we examined the effect of TGF-B1 on 
the intracellular oxidation state in MC3T3-E1 cells. In addi- 
tion, we explored whether alterations in oxidation states are 
involved in modulating egr-1  gene expression. 
Materials and Methods 
Cell Culture 
The mouse osteoblastic cell line, MC3T3-EI  (Kurihara et al.,  1986), and 
its v-Ki-rns-transforraant,  MC3T3-KI  (Nose et al., 1989), were cultured in 
Dulbecco's  modified  medium supplemented with 10% fetal bovine serum 
and 50 ~g/ml kanamycin under a humidified atmosphere of 5% CO2 in air. 
Cells were kept in continuous culture for ~3 mo after thawing. 
Chemicals 
Recombinant human TGF-/~I was obtained from King Brewing Co.  Ltd. 
(Kakogawa,  Japan),  and  12-O-tetradecanoylphorbol-13-acetate,  N-acetyl 
L-cysteine (NAC) and catalase derived from AspergiUus niger were products 
of Sigma Chemical Co. (St. Louis, MO). Pyrrolidine carbodithioic acid am- 
monium (PITIC) was purchased from Nakarai Tesque, Inc. (Kyoto). Potas- 
sium ferricyanide and ascorbic acid were obtained from Wako Pure Chemi- 
cals (Tokyo). NAC and ascorbic acid solutions were adjusted to pH 7.4 by 
the addition of NaOH.  2',7'-dichlorofluorescin  diacetate (DCFH-DA) was 
obtained from Eastman Kodak Corp. (Rochester,  NY). The kinase inhibi- 
tors H-7, H-9,  and W-7 were obtained from Seikagalm  Kogyo (Tokyo). 
Staurosporine was purchased from Kyowa Medix Co.  Ltd.  (Tokyo). 
Assay of IntraceUular Redox State 
Intracellular redox  state levels  were  measured using a  fluorescent dye, 
DCFH-DA.  DCFH-DA is a nonpolar compound that is converted into a 
nonfluorescent polar derivative (DCFH) by cellular esterases after incorlx~ 
ration into cells. DCFH is membrane-impermeable  and rapidly oxidized to 
the highly fluorescent 2',7'-dichlorottuorescein  in the presence of intraceUu- 
lar hydrogen peroxide and peroxidases  (Szejda  et al.,  1984; Bass et al., 
1983).  For assays, medium was replaced with Hanks' solution containing 
5 #M DCFH-DA at appropriate times after stimulation. After 5 min of incu- 
bation at room temperature, the fluorescent intensity of ,~50 cells for each 
point was measured by confocal laser scanning microscopy  (MRCS00;  Bin 
Rad Laboratories, Richmond, CA). The excitation wave length at 513 nm 
was used.  Relative  fluorescence  intensity was calculated using untreated 
control cells as standard. 
RNA Extraction and Analysis 
At ",,80% confluence, the ceils were starved in serum-free DME containing 
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cells were  treated with the agents  for the times indicated in the figure 
legends. Total RNA was extracted using the guanidium/hot phenol method 
(Maniatis et ai., 1982). 20 rig/lane of RNA was electrophoresed on a 1.5 % 
agarose gel containing 2.2 M formaldehyde, blotted onto a nylon membrane 
(Hybond N; Amersbam International, Amersham, UK),  and hybridized 
with probes labeled by nick translation, as described p~ciously (Shiba- 
numa et al.,  1992). The probes used were mouse ot-tubulin eDNA (Mal; 
Lewis et al.,  1985) and "l'GF-ffl-indueible TSC-36  eDNA (Shibanuma et 
al., 1993). Mouse egr-1 eDNA (Tsai-Morris  et al., 1988; Cao et al., 1990) 
was kindly provided by Dr. Sakhatme (University of Chicago, Chicago, IL), 
and a l.l-kb fragment corresponding to nucleotide  1958-3068 was used as 
a probe. 
Nuclear Run-on T?anscription 
Nuclei were isolated from cells treated with TGF-~I in the presence or ab- 
sence of 2.5 mM NAC, and they were transcribed in vitro as described pre- 
viously (Nose et al.,  1991). The 32p-labeled transcripts were isolated and 
hybridized with plasmid DNA  immobilized on nylon membranes.  The 
membranes were washed and autoradiographed. 
Plasmid Construction 
A phage clone containing the complete egr-I  gene, including  the 5'- and 
3'-flanking sequences (Tsai-Morris  et al.,  1988), was isolated from mouse 
liver genomic EMBL3 library (Clonteeh Laboratories, Inc., Palo Alto, CA) 
after screening.  A mouse egr-1 eDNa fragment was used as a probe for the 
screening process.  A 6.l-kb EcoRI fragment was subeloned into pUCll8. 
An EcoRI/SaclI fragment from -1394 to +123 basepairs, containing the 
egr-1 transcriptional  promoter and start site, was subcloned upstream of the 
chloramphenicol acetyltransferase  (CAT) gene in the plasmid pCAT basic 
vector (Promega Corp., Madison, WI) to construct pEgr1394.  5'-deletion 
mutants were prepared by cutting with exonuclease Ill and S1 nuclease,  as 
previously described (Maniatis et ai., 1982). pEgr1394,  875, 417, 393, 356, 
111, 94, and 72 represent the CAT constructs that contain the egr-1 gene 
5'-upstream fragments of indicated numbers of bases counting from the cap 
site down to +123 basepnirs.  The deletion end points were determined by 
dideoxynueleotide  sequencing. 
Transfection and CAT Assay 
Transfection of the CAT constructs (7.5 ~g/100-mm dish) was performed by 
the conventional calcium phosphate precipitation method (Graham and van 
der Eb, 1973; Gorman et al., 1982). 4 h later, the cells were subjected to 
15% glycerol shock and placed in serum-free DME containing 0.1% BSA. 
38 h after the transfection, TGF-~I (5 ng/rul) or H202 (0.2 mM) was added 
for additional 8 h. Cell extracts were prepared as described in Gorman et 
ai. (1982).  CAT activity was measured by a liquid scintillation counting 
method (Neumann et al.,  1987) using cell lysates in 250 ttl of a mixture 
of  10  mM  Tris-HCl  (pH  7.8),  1  mM  chloramphenicol,  and 0.5  ~Ci 
[3H]acetyl CoA. CAT activity was evaluated by calculating increase in dpm 
within a linear range of response. The plasmid pCH110 (5 izg/dish) contain- 
ing the/~-gaiactosidase gene (Pharmacia, Uppsaia, Sweden) was cotrans- 
fected to correct for differences  in transfection efficiency. The activity of 
~-galactosidase  was determined as described by Herbomel et al. (1984). 
Results 
Increase of  lntracellular Oxidized State in MC3T3-EI 
Cells by TGF[31 
Our previous study showed that there was small increase in 
the H202 concentrations in the culture medium after treat- 
ment with TGF-/31, as detected by 3-(p-hydroxyphenyl)-pro- 
pionic acid and horseradish peroxidase assays (Shibanuma et 
al., 1991). In the present study, intracellular oxidized states 
were  measured using  a  more  sensitive fluorescent assay 
method with DCFH-DA  and laser-scanning confocal mi- 
croscopy. The dye is incorporated into ceils and is converted 
to a fluorescent compound by oxidation. The intensity of flu- 
orescence reflects the intracellular oxidized state (Bass et al., 
1983;  Robertson et al.,  1990). 
Quiescent cultures of MC3T3 cells were treated with TGF- 
/~1 (5 ng/ml) for various times. As shown in Figs.  1 A and 
B, the intensity of DCFH fluorescence began to increase 60 
min after treatment, reaching a  maximal level of fivefold 
higher than that in unstimulated cells at 75 min after treat- 
ment. This was followed by a decline in fluorescence to the 
basal level by 120 min. Some ceils showed high fluorescence 
in nuclei, possibly because of accumulation of the dye in nu- 
clear fraction. The maximal level of intracellular fluores- 
cence was comparable to that treated with 10-20 nM 1-1202 
(Fig. 1 C). In a ms-transformed variant of MC3T3 cells (K1) 
that were resistant to TGF-~I through loss of its binding sites 
(Nose et al., 1989), no change in fluorescence intensity was 
observed after treatment with "I'GF-/31 (Fig.  1 B).  These 
results suggested that an increase in the intraceUular oxidized 
state was induced specifically by TGF-/~I through the binding 
to its receptors. 
DCFH can be oxidized by any peroxidase and hydroperox- 
ide, including H202 (Bass et al.,  1983; Keston and Brandt, 
1965). To specify the active oxygen species that were respon- 
sible for the oxidation of DCFH, we examined whether cata- 
lase,  an  enzyme that  specifically  hydrolizes  H202,  pre- 
vented the oxidation of DCFH. MC3T3 cells were treated 
with TGF-/31 in the absence (Fig. 2, top and bottom, column 
B) or presence (Fig. 2, top and bottom, column C) of cata- 
lase (350  U/ml).  The addition of catalase completely in- 
hibited the increase in DCFH oxidation as measured 75 min 
after TGF-ffl treatment.  Heat-inactivated catalase had no 
effect on DCFH oxidation (Fig. 2, top and bottom, column 
E). These findings suggest that H20: participated in DCFH 
oxidation after the TGF-/~I treatment. Nonspecific thiol radi- 
cal scavengers, NAC and PDTC, also inhibited the increase 
in the intracellular oxidized state induced by TGF-~I; NAC 
at 2.5 mM had a 25%  inhibitory effect on the increase in 
DCFH oxidation, and PDTC at 0.1  mM inhibited this in- 
crease by 50%  (data not shown). 
Inhibitory Effect of  Radical Scavengers on the 
Expression of  egr-I Gene by TGF-~I 
We then investigated whether H202 generated by "I'GF-/~I 
plays a role in gene expression. Our previous study demon- 
strated that active oxygens stimulated the expression of the 
immediate early response genes such as c-fos, c-jun, c-myc, 
and egr-1 (Nose et al., 1991). Of these genes, egr-1 was found 
to respond to both TGF-~ and 1-I202 in MC3T3 cells. 
Fig.  3 shows Northern blotting of egr-1 gene at various 
times after treatment with either TGF-~I (2 ng/ml) or H202 
(0.15 mM). H202, at concentrations <0.2 mM, did not af- 
fect cellular viability as determined by dye exclusion test 
and plating efficiency  assay (data not shown). As seen in Fig. 
3, egr-1 gene expression increased within 30 min after stimu- 
lation with TGF-~I, reaching the maximal level  2  h  after 
treatment.  H202-induced  egr-1 mRNA more  rapidly  and 
transiently, reaching a peak within 30 min after the treat- 
ment. Slower induction of egr-1 by TGF-/Yl compared to that 
by H202 showed the delay of ,~90 rain. This delay roughly 
coincided with the time course of changes in the intracellular 
oxidized state determined by the confocal laser scanning mi- 
croscopy (Fig.  1). 
We examined the effects of radical scavengers, i.e. cata- 
lase, NAC, PDTC, potassium ferricyanide (Chaudhri et al., 
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Figure 2. Effects of catalase on the increase in intracellular  oxidized state 
induced by TGF-B1.  Cells were treated for 75 rain with either TGF-B1 
(5  ng/ml)  (B),  TGF-B1  +  catalase (350  U/ml)  (C),  catalase (D),  or 
TGF-~I  +  catalase (heat-inactivated) (E).  Fluorescence intemity was 
measured and calculated as described in the legends to Fig. 1 B. The ex- 
periments were repeated four times, and the results were reproducible. Figure 3. Time course of induction of egr-1 mRNA by TGF B1 and 
H20~.  MC3T3  ceils were either untreated (lane 1), treated with 
TGF-/31 (2 ng/ml) (lanes 2-6),  or H202  (0.15 raM) (lanes  7-11) 
for indicated times. Total RNA was extracted, run on a gel, and 
transferred to membrane filters.  The filters were hybridized with 
32P-labeled  probes,  washed,  and  autoradiographed.  Mouse 
c~-tubulin probe (M c~ 1) was used to monitor the amount of RNA 
in each lane. 
Figure 5. Effects of radical scavengers on the induction of egr-I by 
TPA. Cells were untreated (lanes 1 and 4), or they were treated for 
2 h with 50 ng/ml TPA in the presence (lane 2 and 5) or presence 
of 170 U/nil catalase (lane 3), 2.5 mM NAC (lane 6), 50/~M PDTC 
(lane 7), 5 mM potassium ferrieyanide (lane 8), or 5 mM ascorbic 
acid (lane 9).  RNA was analyzed as described in the legends to 
Fig.  3. 
1988), and vitamin C, on the induction of egr-1 by TGF-/31. 
As  shown  in  Fig.  4  A,  the  addition  of these  antioxidants 
abrogated the induction of egr-1 by TGF-/~I, except for NAC. 
The inhibitory effect of NAC on egr-1  induction  was found 
to be dependent  on its concentrations  (Fig.  4  B).  Catalase 
was very effective in the inhibition  of egr-1  induction  (Fig. 
4 A, lane 7), consistent with oxidized state caused by TGF-/~I 
treatment (Fig.  2). 
These radical  scavengers did not inhibit the induction  of 
another TGF-Bl-inducible gene, TSC-36 (Fig. 4C). Further- 
more,  egr-I  induction  by  12-O-tetradecanoylphorbol-13- 
acetate (TPA) was not affected by these scavengers (Fig.  5). 
These results indicate that the inhibitory effect of scavengers 
was specific for egr-1  gene expression induced  by TGF-~. 
A  nuclear run-on assay was carried out to test whether the 
induction of egr-1 by TGF-BI, and its inhibition by NAC were 
regulated  at the transcriptional  level.  As  shown  in Fig.  6, 
TGF-/~l-activated transcription  of egr-1  gene,  and  NAC  at 
2.5  mM led to the reduction  of this  TGF-/31-induced tran- 
scription. Shorter exposure of the film showed that transcrip- 
Figure 4. Effects of radical scavengers on the induction of egr-1 and 
TSC-36 mRNA by TGF-B1. (A) MC3T3 cells were either untreated 
(lane 1 ), or they were treated with TGF-31 (2 ng/ml) in the absence 
(lane 2) or presence of 0.5 raM NAC (lane 3), 50/~M PDTC (lane 
4), 5 mM potassium ferricyanide (K-Ferr; lane 5), 5 mM ascorbic 
acid (V/t.C; lane 6), or 170 U/ml catalase (cat; lane 7) for 2 h. (B) 
Cells were untreated (lane 1 ), or they were treated with TGF-/31 
(2 ng/ml) in the absence (lane 2) or presence of increasing concen- 
trations (lane 3-7, 0.1, 0.5,  1.0, 2.5, and 5.0 mM, respectively) of 
NAC. (C) Cells were untreated (lane 1 ), or they were treated with 
2 ng/ml TGF-/~I in the absence (lane 2) or presence of 170 U/ml 
catalase (lane 3), 2.5 mM NAC (lane 4), or 50/~M PDTC (lane 
5)  for 8  h.  RNA was analyzed using  32P-labeled probes as de- 
scribed in the legend to Fig.  3. 
Figure 6.  Nuclear  run-on  assay.  Nuclei  were isolated  from un- 
treated cells (lane 1 ), and from cells treated with TGF-/~I (2 ng/ml) 
for 90 min in the absence (lane 2) or presence of 2.5 mM NAC (lane 
3),  and were transcribed in the presence of [32P]UTP. The tran- 
scripts  were  hybridized  with  the  probes  immobilized  on mem- 
branes. The membranes were washed and autoradiographed. 
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Figure 7.  Schematic representation of egr-1/CAT constructs and 
stimulation of egr-1 enhancer by TGF-8I and H202. MC3T3 cells 
were transfected with each plasmid by the  calcium phosphate 
precipitation method, and they were cultured in DME containing 
1 mg/ml BSA for 38 h. The cells were either untreated, or they were 
treated with TGF-/~I (5 ng/ml) or 0.2 mM H202. Cells were har- 
vested 8 h later, and CAT activity was measured. (,4) a, Untreated; 
b, TGF-/~l-treated; c, H202-treated. "values indicate relative CAT 
activity. (B) Relative CAT activity of serial deletion constructs in 
TGF-Bl-treated and H202-treated cells. Open and closed boxes in- 
dicate sites containing CArG and AP-1 elements, respectively.  The 
experiments were carried out three times, and the results show the 
means +  standard deviation. 
tion of Mcxl stayed constant during 90 rain after treatment 
period (data not shown). 
A  Common l~rget Sequence for TGF-{31- and 1-1202 
Stimulation of egr-1 Gene Transcription 
To elucidate the transcriptional regulatory mechanism re- 
sponsible for redox-mediated TGF-/~I signal transduction, 
we attempted to identify a common cis-aeting DNA element 
for both TGF-~I and H202.  For this purpose, the deletion 
mutants upstream of the transcriptional start site of the egr-1 
gene were fused to a CAT reporter gene. The mouse egr-1 
upstream region contains five CC(A/T)tGG (CArG) boxes 
plus  the  incomplete  CCAATATCK?~  sequence  (position 
-340 to -331 bp, Tsai-Morris et al.,  1988).  These CArG 
elements were progressively deleted from pEgr1394, a plas- 
mid containing the mouse egr-1  upstream region between 
-1394 to  +123 bp with five CArG elements and two AP- 
l-like elements (Fig. 7). 
The highest CAT  activity was observed  with pEgr417, 
which contained all five CArG elements, in cells treated ei- 
ther with TGF-/~I or H202 (Fig. 7 B). Treatment with TGF- 
/~1 or H202 led to a 2.3- and 3.5-fold increase in CAT activ- 
ity, respectively, compared to that of unstimulated cells. A 
progressive  decrease  in  response  was  observed  as  each 
CArG element was deleted. Removal of the three CArG ele- 
ments from the Y-end (pEgrl 11) resulted in very weak indue- 
tion by both agents, indicating that TGF-/~I and H202  re- 
quire at least three CArG elements from the cap site for the 
induction. The above findings identify  the CArG elements as 
a common target sequence for both TGF-~I and H202. 
Effects of  Protein Kinase Inhibitors on the 
Expression of egr-1 
Protein kinases participate in signal transductions elicited by 
diverse stimuli. Possible involvement of protein kinases in 
the redox-mediated signaling pathways was examined by pro- 
tein kinase inhibitors. The results of Northern blots show 
that 50/~M of H-7, an inhibitor of protein kinases C, A, and 
G, repressed almost completely the egr-1 induction by TGF- 
/51  and H202 (Fig.  8).  However,  neither staurosporine,  a 
potent inhibitor of protein kinase C, nor H-9, an inhibitor of 
cAMP-dependent kinase,  affected the  egr-1  induction by 
TGF-/31 and  H202.  Moreover,  the  induction of egr-1  by 
TGF-/31 was retained in the protein kinase C-downregulated 
cells after prolonged treatment with TPA (24 h) (data not 
shown). Based on these observations, we postulate that an 
H-7-sensitive kinase, but not protein kinase C, might be in- 
volved in the gene expression of egr-I by TGF-~ and H202. 
Discussion 
In the present study, we demonstrated that TGF-/51 increased 
the intracellular oxidized state in mouse osteoblastic cells, 
but not in a TGF-/31 receptor-deficient variant. This increase 
was almost completely abolished by the addition of catalase, 
indicating that H202 was a  major cause of increased oxi- 
dized state. The production of H202 was also blocked, al- 
beit to a lesser extent, by the nonspecific thiol agents, NAC 
and PDq'C. NAC raises the levels of intracellular glutathione 
(GSH), which controls the cellular redox state as a substrate 
of GSH  peroxidase.  In  addition,  NAC  and  PDTC  both 
directly quench intracellular free radical (Staal et al., 1990). 
Catalase, on the other hand, cannot be incorporated into 
cells, thereby acting on the outside of the cells. These results 
suggest that H202 might be first released from the cells af- 
ter treatment with TGF-/31, and then diffused into the cells. 
In the previous study (Shibanuma et al.,  1991), we mea- 
sured levels of H202 in the medium by using 3-(p-hydrox- 
yphenyl)-propioaic acid and horseradish peroxidase, and we 
detected H202 in the medium of cells stimulated by TGF-/31 
only in cells at G~ phase and not in Go phase cells. In the 
present study, however,  the method using DCFH-DA and 
confocal laser microscopy made it possible to detect the in- 
crease of  the intracellular oxidative state. Consistent with the 
previous work, the increase in the intracellular oxidative 
state was more pronounced and sustained in cells in late G1 
phase (data not shown). 
The pathways for generation of free radicals in MC3T3 
cells are not fully understood. NAD(P)H oxidase, which 
produces superoxide anion from 02, is known to be local- 
ized in the outer cell membrane (Ramasarma, 1982). In neu- 
trophils and macrophages, burst of oxygen radical occurs 
within seconds after stimulation (Sagone et al., 1976; Frido- 
vich,  1983).  In contrast, the change in redox state in re- 
sponse to TGF-/31 was slow and transient. In addition, radi- 
cal scavengers did not inhibit egr-1 induction by TPA, which 
is known to activate NAD(P)H oxidase (Maridonneau-Parinl, 
Ohba et al. H:02 as a Signal of lGF-l~l  1085 1986).  Thus,  the generating system of H202  activated by 
TGF-/31 in MC3T3 cells seems to be distinct from the NAD- 
(P)H oxidase system, probably because of a specific, still- 
unknown generating system. 
Changes in the redox state of cells are thought to induce 
modifications  of cellular signaling molecules, including pro- 
tein kinases, protein phosphatases, and transcription factors. 
Regulation by redox of a portion tyrosine kinase (Bauskin et 
al.,  1991; Devary et al.,  1992)  and a protein phosphatase 
(Guy et al.,  1993)  has also been reported.  In the present 
study, possible biological roles of oxidized state in gene ex- 
pression was studied with the egr-1 gene, which was tran- 
scriptionally  activated  by  both  TGF-~I  and  H202. The 
results of Fig. 4, A and B, show that scavengers for active oxy- 
gens specifically inhibited the induction of egr-1 by TGF-B1, 
indicating that the action of TGF-/51 is regulated by redox, 
at least in term of egr-1 gene transcription. 
CAT assay using the egr-1 promoter region indicated that 
the CArG element is a common target for the transcriptional 
activation of egr-1 by both  TGF-/51 and  I-I202. A  recent 
finding (Datta et al., 1993) demonstrated that the transcrip- 
tion induction of egr-1 caused by ionizing radiation also re- 
quired CArG elements. The involvement of active oxygens 
in this transcriptional activation was implied from the ex- 
periment with NAC. The CArG element is known to bind to 
serum response factor, whose binding activity is enhanced 
by its phosphorylation (Treisman,  1993). 
Recent observations provide evidence that redox regula- 
tion is a general mechanism for the posttranslational control 
of transcription factor function. Changes in reduction-oxi- 
dation potential have been shown to influence the DNA bind- 
ing activity of several  transcription  factors,  such as Oxy 
R (Storz et al.,  1990),  FOS/JUN (Abate et al.,  1990) and 
NFKB (Schreck et al., 1991). Oxy R is a best example of this 
redox regulation in the direct activation of a transcription 
factor in bacterial systems. DNA-binding activity of mam- 
malian FOS/JUN is reported to be modified by the oxidation 
of their cysteine residues (Abate et al., 1990).  Most of these 
works are, however, limited to in vitro experiments, and our 
present results indicate that redox regulation of transcription 
exists in vivo as well. 
Active oxygens are produced by various types of cultured 
cells under the influence of numerous stimuli (Meier et al., 
1989; Robertson et al.,  1990).  They are generally regarded 
Figure 8. Effects  of protein kinase inhibitors on egr-1 induction by 
TGF-BI or  H202.  Cells were untreated (lane /),  or they were 
treated with 2 ng/ml TGF-B1 (A) or 0.15 mM H202 (B) for 2 h in 
the absence (lane 2) or presence of 50 ttM H-7 (lane 3), H-9 (lane 
4), W-7 (lane 5), or 0.5 ~M staumsporine (sp, lane 6). RNA was 
extracted and analyzed as described in the legend to Fig. 3. 
as harmful to cells, because they modify cellular macro- 
molecules, including lipids, proteins, carbohydrates, and nu- 
cleic acids. Cells have several different types of systems to 
protect  them  against  such  free  radical-induced damages; 
systems involving intracellular glutathione, catalase, super- 
oxide dismutases, and glutathione peroxidase (Fridovich, 
1978; Meister, 1983).  Most active oxygens can be deleteri- 
ous to ceils, but cytokines, especially suppressors of growth 
such as tumor necrosis factor-tx and interleukin-1,  are known 
to stimulate cells to produce active oxygens (Beutler and 
Cerami,  1986;  Meier et al.,  1989). 
We previously proposed that active oxygens can work as 
a  competence  factor  for  growth  in  quiescent  fibroblasts 
(Shibanuma et al., 1990). It now seems reasonable to believe 
that active oxygens at certain levels could work as biosignals 
in  physiological  conditions.  The  molecular  mechanisms 
responsible for such signals may include direct oxidation of 
protein  factors by  sulfenylation (Storz  et  al.,  1990)  and 
S-thiolation (Gilbert, 1984).  Our results with the inhibitors 
of protein kinases indicate that the activation of H-7-sensi- 
tive protein kinase(s) is necessary for the induction of egr-I 
by either TGF431 or H202, and such kinase(s) could be a di- 
rect  target  of redox  regulation.  Protein  kinases  that  are 
stimulated by interleukin-1  and tumor necrosis factor (Gues- 
don et al.,  1993) could be regulated by redox. 
The best example of the second messenger actions of ac- 
tive oxygen species is nitric oxide. Nitric oxide is one mem- 
ber of active oxygen species, and is well known as a major 
messenger molecule regulating immune function and blood 
vessel dilatation. It also serves as a neurotransmitter in the 
brain and peripheral nervous system (Lowenstein and Sny- 
der, 1992). We propose that hydrogen peroxide could be an- 
other member of active oxygens that operates as a second 
messenger in growth factor signalings. 
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